Company Description
Ardent Health Partners is the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States.
We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas.
We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us.
We provide both general and specialty services, including internal medicine, general surgery, cardiology, oncology, orthopedics, women’s services, neurology, urology, and emergency services, within inpatient and ambulatory care settings.
In addition to our 30 acute care hospitals, we operate a broad network of ambulatory facilities and telehealth services.
We operate either independently or in partnership with premier academic medical centers, large not-for-profit hospital systems, community physicians, and a community foundation.
Collectively, we operate as a unified organization with a consumer-centric approach to caring for our patients and our communities.
Country | United States |
Founded | 2001 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 24,200 |
CEO | Martin J. Bonick |
Contact Details
Address: 340 Seven Springs Way, Suite 100 Brentwood, TN 37027 United States | |
Phone | (615) 296-3000 |
Website | ardenthealth.com |
Stock Details
Ticker Symbol | ARDT |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001756655 |
Employer ID | 61-1764793 |
SIC Code | 8062 |
Key Executives
Name | Position |
---|---|
Martin J. Bonick | President and Chief Executive Officer, Director |
Alfred Lumsdaine | Chief Financial Officer |
Stephen C. Petrovich | Executive Vice President, General Counsel and Secretary |
David Schultz | President of Hospital Operations |
Ethan Chernin | President of Health Services |
Mark Sotir | Chair of the Board |
Peter Bulgarelli | Director |
Peter Bynoe | Director |
Suzanne Campion | Director |
William Goodyear | Director |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 21, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Jun 3, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Apr 26, 2024 | DRS/A | [Amend] [Cover] Draft Registration Statement |
Mar 15, 2024 | DRS | [Cover] Draft Registration Statement |
Jan 8, 2020 | RW | Filing |
Mar 6, 2019 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Dec 21, 2018 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
Dec 4, 2018 | S-1 | General form for registration of securities under the Securities Act of 1933 |
Oct 26, 2018 | DRS | [Cover] Draft Registration Statement |